[ET Net News Agency, 1 November 2021] Credit Suisse lowered its target price for Junshi
Bio (01877) to HK$57 from HK$61 and maintained its "outperform" rating.
The research house said it revises up FY21/22 EPS by 29.5%/5% and revises down FY23 EPS
by >4,400% (from -0.01 to -0.21) due to changes in gross margin, operation expense, and
share count. (RC)